Table of Contents
Research & Development
| Novo Nordisk Signs US$252.6 M Deal with EraCal to Boost Obesity Portfolio | Abstract pdf html |
| Amit Kaushik |
Mergers & Acquisitions
| Merck & Co. to Acquire Harpoon Therapeutics for US$680 M | Abstract pdf html |
| Ayush Saxena |
| Novartis to Acquire MorphoSys for US$2.9 B to Expand Oncology Pipeline | Abstract pdf html |
| Lalit Mishra |
| Sanofi Acquires Rare Disease Developer Inhibrx for up to US$2.2 B | Abstract pdf html |
| Ashish Tripathi |
This work is licensed under a Creative Commons Attribution 3.0 License.